Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers

Journal of Clinical Pharmacology

Volumn 40, Issue 12 I, 2000, Pages 1338-1346

  Stangier, Joachim ^a   Su, Chung An P F ^a   Fraunhofer, A ^b   Tetzloff, W ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b IPHAR Institute for Clinical Pharmacology GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PARACETAMOL; TELMISARTAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; LEG EDEMA; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; STATISTICAL ANALYSIS; STEADY STATE;

ACETAMINOPHEN; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; CROSS-OVER STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED;

EID: 0033749283     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127000004001205     Document Type: Article

References (28)

1. Rationale and pharmacology of angiotensin II receptor antagonists: Current status and future issues
2. Angiotensin II receptors and angiotensin II receptor antagonists
3. A new class of antihypertensive therapy: Angiotensin II receptor antagonists
4. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension
5. Effect of enalapril on the skin response to bradykinin in man
6. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: Synthesis, biological activity, and structure-activity relationships
7. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277
8. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension
9. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan to amlodipine
10. The incidence of cough: A comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist
11. Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension
12. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
13. The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesics for patients at risk
14. Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: Intestinal chiral inversion
15. 14C]telmisartan in healthy volunteers
16. Reference tables for the intrasubject coefficient of variation in bioequivalence studies
17. Sample size determination for proving equivalence based on the ratio of two means for normally distributed data
18. Update on the statistical analysis of bioequivalence studies
19. A distribution-free procedure for the statistical analysis of bioequivalence studies
20. Clinical pharmacokinetics of telmisartan
21. Clinical pharmacokinetics of ibuprofen
22. Telmisartan Blood Pressure Monitoring Group: ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension
23. Circadian variation in the frequency of onset of acute myocardial infarction
24. Circadian variation and triggering of cardiovascular events
25. Disposition and covalent binding of ibuprofen and its acylglucuronide in the elderly
26. Disposition and chemical stability of telmisartan 1-O-acylglucuronide